drugset / Trial / NCT06541145

Bacterial Decolonization Within Dyads

NCT06541145

Non-randomizedSingle-groupOpen-labelPrevention

Summary

The goal of this study is to measure bacterial burden, specifically Staph aureus, and how it spreads between mothers and their infants. Researchers will evaluate if the amount of bacteria on their skin remains the same after mothers use a skin antisepsis treatment prior to delivering their infants. The investigators also aim to assess participant interest in and compliance with skin antisepsis treatments. The hypothesis is that increased maternal interest will align with increased treatment compliance.

Timeline

Start
2024-08-21
Primary completion
2024-10-18
Completion
2024-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule Topical
Subject Mupirocin Small molecule 2 % Intranasal

Indications

No indication recorded.